In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria. 2001

H M Wexler, and E Molitoris, and D Molitoris, and S M Finegold
Research Services, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.

In a previous study, we compared HMR 3004 with azithromycin, clarithromycin, erythromycin and roxithromycin against 502 anaerobic bacteria using NCCLS-approved procedures. This report extends this study by reporting the activity of telithromycin (HMR 3647) against these strains. Telithromycin inhibited 10% of Bacteroides fragilis, 50% of other B. fragilis group organisms and 93% of other Bacteroides spp. Telithromycin inhibited all Porphyromonas spp. and 98% of Prevotella spp. Activity against Bilophila wadsworthia (85-96%) was excellent. Telithromycin was not active against the Fusobacterium mortiferum/varium group. Telithromycin inhibited 100% of Clostridium perfringens, 46-56% of Clostridium difficile and Clostridium ramosum and approximately 90% of non-spore-forming Gram-positive bacilli.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001421 Bacteria, Anaerobic Bacteria that can survive and grow in the complete, or nearly complete absence of oxygen. Anaerobic Bacteria
D048628 Ketolides Compounds based on ERYTHROMYCIN with the 3-cladinose replaced by a ketone. They bind the 23S part of 70S bacterial RIBOSOMES. 3-Keto-Erythromycins,Erythromycins, 3-Keto,3 Keto Erythromycins,3-Keto Erythromycins,Erythromycins, 3 Keto
D018942 Macrolides A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties. Macrolide

Related Publications

H M Wexler, and E Molitoris, and D Molitoris, and S M Finegold
August 1998, Journal of chemotherapy (Florence, Italy),
H M Wexler, and E Molitoris, and D Molitoris, and S M Finegold
July 2000, The Journal of antimicrobial chemotherapy,
H M Wexler, and E Molitoris, and D Molitoris, and S M Finegold
August 1999, Antimicrobial agents and chemotherapy,
H M Wexler, and E Molitoris, and D Molitoris, and S M Finegold
July 2000, Antimicrobial agents and chemotherapy,
H M Wexler, and E Molitoris, and D Molitoris, and S M Finegold
September 2001, Drugs of today (Barcelona, Spain : 1998),
H M Wexler, and E Molitoris, and D Molitoris, and S M Finegold
September 1998, The Journal of antimicrobial chemotherapy,
H M Wexler, and E Molitoris, and D Molitoris, and S M Finegold
March 2001, Antimicrobial agents and chemotherapy,
H M Wexler, and E Molitoris, and D Molitoris, and S M Finegold
April 1999, Antimicrobial agents and chemotherapy,
H M Wexler, and E Molitoris, and D Molitoris, and S M Finegold
December 2000, Antimicrobial agents and chemotherapy,
H M Wexler, and E Molitoris, and D Molitoris, and S M Finegold
April 2001, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!